← Back to Search

Behavioural Intervention

Resistance Exercise for Osteoporosis

N/A
Waitlist Available
Led By HARSHVARDHAN SINGH, PT, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with low bone mass
Independent ambulatory
Must not have
History of cancer in the past 5 years
Secondary osteoporosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new muscle-strengthening exercise to see if it is feasible for postmenopausal women with low bone mass.

Who is the study for?
This trial is for postmenopausal women who can walk on their own and have been diagnosed with low bone mass. It's not suitable for those with secondary osteoporosis, uncontrolled high blood pressure, current non-zoledronic acid osteoporosis treatments, liver or kidney disease, unmanaged thyroid issues, recent cancer history, previous year resistance training, inability to walk independently or a fragility fracture.
What is being tested?
The study tests a new muscle-strengthening exercise program over six months to see if it's doable for women with weak bones after menopause. Participants are randomly chosen to either join the exercise group or be in a control group without this specific training.
What are the potential side effects?
Since the intervention involves physical exercise training, potential side effects may include muscle soreness, joint pain or discomfort during and after workouts. However, these are common reactions to starting any new workout regimen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with low bone density.
Select...
I can walk by myself without help.
Select...
I can walk by myself without help.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had cancer within the last 5 years.
Select...
My bone loss is due to an underlying health condition.
Select...
I have had a fracture from a minor injury.
Select...
I have liver or kidney disease.
Select...
I have taken medication for osteoporosis before.
Select...
I am currently being treated for osteoporosis, but not with zoledronic acid.
Select...
I cannot walk on my own.
Select...
My blood pressure is not controlled by medication.
Select...
My thyroid or parathyroid glands are not functioning properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bone biomarker
Secondary study objectives
Muscle strength
Oxygen uptake (VO2)
Physical activity: International Physical Activity Questionnaire (IPAQ)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise trainingExperimental Treatment1 Intervention
The exercise training group will receive progressive muscle resistive exercise, 10 sets of exercises for 2 times per week for a total of 6 months.
Group II: ControlActive Control1 Intervention
The control group will be asked to maintain their normal lifestyle and will be advised to continue their standard care of treatment.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,672 Total Patients Enrolled
17 Trials studying Osteoporosis
593,420 Patients Enrolled for Osteoporosis
HARSHVARDHAN SINGH, PT, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Novel Resistance Exercise (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05060380 — N/A
Osteoporosis Research Study Groups: Exercise training, Control
Osteoporosis Clinical Trial 2023: Novel Resistance Exercise Highlights & Side Effects. Trial Name: NCT05060380 — N/A
Novel Resistance Exercise (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05060380 — N/A
Osteoporosis Patient Testimony for trial: Trial Name: NCT05060380 — N/A
~29 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top